The Cheney Cardiovascular Institute Release: Genomics of Cardiovascular Disease; Current Clinical Applications

KEYNOTE SPEAKER - Kari Stefansson, MD, DR. MED, CEO DeCODE Genetics

WASHINGTON, June 5 /PRNewswire-USNewswire/ -- The following media advisory was issued today by The Cheney Cardiovascular Institute:

Date: Thursday, June 12, 2008

Location: The George Washington University Hospital Auditorium

900 23rd Street, NW

Time: Noon - 2:50pm

Noon - 1:00pm Presentation by Dr. Kari Stefansson

Dr. Stefansson is CEO and co-founder of deCODE genetics and a former professor of neurology, neuropathology, and neuroscience at Harvard University.

The deCODE group has identified unique genomic markers for atherosclerosis, atrial fibrillation, and type II diabetes mellitus. As one of the world's leading experts on genomics, Dr. Stefansson will discuss the current clinical applications of cardiovascular personalized medicine. Key to understanding the potential of genomics, Dr. Stefansson will define single nucleotide polymorphisms (SNPs) and their role in genetic diseases. His talk will highlight the breakthroughs in cardiovascular genomics for both clinical cardiologists as well as researchers.

1:15 - 2:50pm Luncheon panel discussion -

Moderated by Timothy McCaffrey, PhD

Stephen B. Liggett, MD

Professor of Medicine and Physiology

Director, Cardiopulmonary Genomics

University of Maryland School of Medicine

Timothy McCaffrey, PhD

Professor of Biochemistry and Director, McCormick Genomics Center, The George Washington University School of Medicine

Gualberto Ruano, MD, PhD

President and CEO, Genomas, Inc.

The Richard B. and Lynne V. Cheney Cardiovascular Institute at The George Washington University was established in 2006 by a generous charitable contribution from Vice President Richard Cheney and his wife Lynne.

The mission of The Richard B. and Lynne V. Cheney Cardiovascular Institute is to promote clinical research, education, patient care and community service with the goal of accelerating the pace of scientific discovery, reducing mortality and improving the quality of life of Americans with cardiovascular disease. To achieve these goals, the Institute seeks to provide an interdisciplinary structure to integrate basic and clinical investigators, clinicians, medical educators, health policy experts and community leaders. For more information, please visit www.cheneycardioinstitute.com.

CONTACT: David Garofalo of GW Medical Faculty Associates, +1-202-741-3381,
dgarofalo@mfa.gwu.edu

Web site: http://www.cheneycardioinstitute.com/

Back to news